[Lymphadenopathy in phenytoin treatment]
- PMID: 100800
[Lymphadenopathy in phenytoin treatment]
Abstract
The authors report on a 20-year-old patient who developed hydantoin lymphadenopathy during treatment with diphenylhydantoin. The problems associated with clinical and histological delimination from malignant lymphomata are described by reference to the literature. Hydantoin lymphadenopathy is regarded as a drug-induced allergic and toxic process.
Similar articles
-
[Lymphadenopathy in phenytoin treatment (author's transl)].Dtsch Med Wochenschr. 1976 Oct 1;101(40):1454-6. doi: 10.1055/s-0028-1104291. Dtsch Med Wochenschr. 1976. PMID: 823005 German.
-
Hydantoin-induced pseudo-pseudolymphoma.Ann Intern Med. 1968 Sep;69(3):557-68. doi: 10.7326/0003-4819-69-3-557. Ann Intern Med. 1968. PMID: 4970555 No abstract available.
-
Hydantoin lymphadenopathy.J Pathol Bacteriol. 1968 Jan;95(1):314-7. doi: 10.1002/path.1700950141. J Pathol Bacteriol. 1968. PMID: 5643463 No abstract available.
-
Diphenylhydantoin-induced hepatic necrosis. A case study.Gastroenterology. 1976 Mar;70(3):422-4. Gastroenterology. 1976. PMID: 814030 Review.
-
Lymphadenopathy simulating the malignant lymphomas.Hum Pathol. 1974 Sep;5(5):519-50. doi: 10.1016/s0046-8177(74)80005-5. Hum Pathol. 1974. PMID: 4137045 Review. No abstract available.